title: AstraZeneca reprimanded for nolvadex advertisement.
authors.forename: Lou
authors.initials: L
authors.lastname: Fintor
mesh_terms: D000329:Advertising / Q000592:standards*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D004345:Drug Industry / Q000592:standards*; D006801:Humans; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects; D013629:Tamoxifen / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018931:Antineoplastic Agents, Hormonal; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen